A total cholesterol reading of 256 mg/dL falls into the “high” category, which generally begins at 240 mg/dL. It sits well above the desirable range (under 200 mg/dL) and signals that something in your lipid metabolism needs attention. But how urgently you need to act, and what form that action should take, depends on factors that a single number on a lab printout cannot capture.
What 256 Actually Tells You and What It Doesn’t
Total cholesterol is a composite number. It bundles together your LDL (often called “bad” cholesterol), your HDL (“good” cholesterol), and a fraction of your triglycerides into one figure. Two people can both have a total cholesterol of 256 and face very different levels of risk. One person might have high HDL pushing the total up, along with moderate LDL and low triglycerides. Another might have dangerously high LDL, low HDL, and elevated triglycerides. The second person is in considerably more trouble.
This is why your doctor will focus on the full lipid panel rather than the headline number. LDL cholesterol is the main driver of plaque buildup in your arteries. When LDL particles accumulate in artery walls, they become oxidized and trigger an inflammatory cascade: immune cells rush in, absorb the modified cholesterol, and form fatty deposits that gradually narrow the vessel.1PubMed Central. Mathematical modelling of atheroma plaque formation and development in coronary arteries Over years, these deposits can harden or rupture, leading to heart attacks and strokes. HDL cholesterol, on the other hand, helps shuttle excess cholesterol back to the liver for disposal. So when your total is 256, the question your clinician is really asking is: how much of that 256 is LDL, and how much is HDL doing its job?
Common Reasons Your Cholesterol Lands at 256
For most people with a reading in this range, the cause is some combination of diet, body composition, and genetics rather than a single smoking gun. Saturated fat in the diet has a well-established role in raising LDL cholesterol, more so than the cholesterol you eat directly from foods like eggs.2PubMed Central. Dietary saturated fat and cholesterol: cracking the myths around eggs and cardiovascular disease That said, people respond to dietary fat differently. Some individuals are “hyper-responders” whose LDL climbs steeply with saturated fat intake; others see more modest changes. Carrying excess weight, particularly visceral fat around the midsection, tends to push LDL up and HDL down.
Genetics can also be a big player. If high cholesterol runs in your family, there may be inherited traits that slow how efficiently your liver clears LDL from the blood. In its most extreme form, this is familial hypercholesterolemia (FH), a genetic condition that can push LDL well above 190 mg/dL. Among people with LDL that high, though, only a small fraction actually carry a known FH mutation. In one large study of over 20,000 people without coronary artery disease, about 7% had LDL at or above 190 mg/dL, and fewer than 2% of those carried an identifiable FH-causing gene variant.3PubMed Central. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia The majority of people with elevated cholesterol have what researchers call “polygenic” high cholesterol, meaning many small genetic influences add up rather than one single gene being responsible.
Medical Conditions That Raise Cholesterol
Before assuming your 256 reading is purely about diet or genetics, it’s worth ruling out secondary causes. An underactive thyroid (hypothyroidism) is one of the most common medical conditions that quietly raises cholesterol. Thyroid hormones help regulate how your liver processes LDL; when thyroid function drops, LDL clearance slows and cholesterol climbs. Treating the thyroid problem with replacement hormone often improves the lipid profile on its own.4PubMed Central. Effects of thyroid dysfunction on lipid profile
Kidney disease is another culprit. Nephrotic syndrome, a condition where the kidneys leak large amounts of protein into the urine, causes dramatic increases in total cholesterol, LDL, and other lipid particles. The underlying changes affect nearly every step in how the body makes, transports, and breaks down fats.5PubMed Central. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences Diabetes, liver disease, and certain medications (corticosteroids, some blood pressure drugs) can also shift cholesterol upward. A doctor seeing a total cholesterol of 256 for the first time should consider basic screening for these conditions before attributing everything to lifestyle.
How Hormones and Aging Shift the Numbers
If you’re a woman who recently went through menopause and noticed your cholesterol climbing, you’re not imagining the connection. Estrogen helps the liver clear LDL from the bloodstream, and as estrogen levels drop after menopause, LDL tends to rise and HDL often dips. Research on estrogen replacement has shown that oral estrogen at standard doses can lower LDL cholesterol by roughly 15 to 19 percent, largely by speeding up the rate at which LDL is removed from circulation.6PubMed. Effects of Postmenopausal Estrogen Replacement on the Concentrations and Metabolism of Plasma Lipoproteins That doesn’t mean hormone therapy is the right cholesterol fix for everyone, since it carries its own set of risks and benefits that go far beyond lipids. But it does help explain why a woman with perfectly normal cholesterol at 45 might find herself at 256 by 55 without any major change in diet or exercise.
Men see a more gradual rise with age, partly because testosterone levels decline slowly and the liver’s efficiency at clearing LDL drifts downward over decades. The combination of age-related changes in metabolism, creeping weight gain, and reduced physical activity means that cholesterol levels in the 250s become quite common in middle-aged and older adults, even those who eat reasonably well.
Dietary and Lifestyle Approaches
When your total cholesterol is 256, lifestyle changes are typically the first recommendation, and they can genuinely move the needle. The dietary lever that matters most for LDL reduction is swapping saturated fat for unsaturated fat. Replacing butter, fatty cuts of meat, and full-fat dairy with sources of monounsaturated fat (olive oil, avocados, nuts) and polyunsaturated fat (fatty fish, flaxseed) consistently lowers LDL in clinical studies.7PubMed Central. Saturated fatty acids and risk of coronary heart disease: modulation by replacement nutrients The magnitude of the effect varies from person to person, but most people can expect a meaningful drop.
Soluble fiber also helps. Foods like oats, barley, beans, lentils, and psyllium husk interfere with cholesterol absorption in the gut, effectively preventing some of the cholesterol your liver sends into your intestines from being reabsorbed. Plant sterols and stanols, which are found naturally in small amounts in grains and vegetables and are sometimes added to margarines and orange juice, work through a similar mechanism.8PubMed. Reduction in intestinal cholesterol absorption by various food components: mechanisms and implications Adding two to three grams of plant sterols per day on top of a healthy diet can shave off an additional chunk of LDL.
Exercise helps too, though its biggest effect is on HDL and triglycerides rather than LDL. Aerobic activity tends to raise HDL and lower triglycerides, while resistance training adds a complementary benefit. Combining both types appears to produce the best overall lipid improvements.9PubMed Central. Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations Even moderate improvements in fitness matter. Someone who goes from sedentary to regularly active can expect lipid changes that, while not dramatic on their own, compound with dietary improvements.
When Medication Enters the Conversation
Lifestyle changes have their limits, especially when genetics are heavily involved. If diet and exercise haven’t brought your numbers to an acceptable range after a few months, or if your overall cardiovascular risk is high enough to warrant faster action, medication becomes the standard next step.
Statins remain the backbone of cholesterol-lowering therapy. They work by blocking an enzyme in the liver that produces cholesterol, which forces liver cells to pull more LDL out of the bloodstream to compensate.10Current Drug Safety. Adverse Effects of Statins – Mechanisms and Consequences Beyond lowering LDL, statins have shown actual plaque regression in arteries. One imaging study found measurable shrinkage of artery plaque within six months of statin therapy, and the degree of plaque reduction tracked closely with how much LDL cholesterol dropped.11PubMed. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy
Modeling of the U.S. adult population suggests that treating all statin-eligible adults could prevent an estimated 243,000 cardiovascular events per year.12PubMed Central. 2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals Those are real heart attacks and strokes avoided, which is why guidelines are fairly aggressive about recommending statins for people whose risk profile warrants them.
For people who need additional lowering beyond what a statin provides, ezetimibe is often added. It works differently, blocking cholesterol absorption in the small intestine rather than production in the liver. In a large trial of patients who had recently experienced a heart event, adding ezetimibe to a statin further reduced cardiovascular events compared to statin therapy alone.13PubMed. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes For the highest-risk patients, or those with genetically driven very high LDL, a newer class of injectable drugs called PCSK9 inhibitors can produce dramatic LDL reductions by preventing the liver from breaking down the receptors that clear LDL from the blood.14PubMed Central. PCSK9 inhibitors – mechanisms of action
The Nocebo Effect and Statin Side Effects
One of the biggest practical obstacles to cholesterol treatment isn’t the medication itself; it’s what people believe about the medication. Muscle pain is the side effect most commonly attributed to statins, and it’s the reason many people stop taking them. But the evidence suggests that a large portion of these complaints are driven by the nocebo effect, where expecting a side effect causes you to experience it. Muscle symptoms are reported far more often in real-world observational studies, where patients know they’re on a statin, than in blinded clinical trials, where they don’t know whether they’re taking the drug or a placebo.15PubMed. Muscle and statins: from toxicity to the nocebo effect
An analysis of adverse events reported to the FDA found that subjective complaints (muscle aches, fatigue, brain fog) were reported far more often for statins than objective, measurable side effects. These subjective reports were also more common in the U.S. than in other countries, consistent with the idea that media coverage and cultural expectations amplify the nocebo effect.16PubMed. Examining the Nocebo Effect of Statins Through Statin Adverse Events Reported in the Food and Drug Administration Adverse Event Reporting System None of this means statin side effects are imaginary. Real muscle toxicity does occur in a small number of patients. But if your doctor prescribes a statin for a cholesterol level of 256 and you’ve read online that statins will make your muscles ache, you’re primed to notice and attribute normal aches to the pill. Clinicians increasingly recommend not stopping the medication at the first hint of discomfort, instead trialing a different statin or dose before giving up.17JAMA. Nocebo Effect May Account for Statin Adverse Events
Beyond LDL: Markers That Refine the Picture
Standard lipid panels report LDL cholesterol, but researchers have increasingly argued that apolipoprotein B (apoB) is a better measure of cardiovascular risk. ApoB is a protein found on every atherogenic lipoprotein particle. Your LDL number estimates the amount of cholesterol carried by those particles, but apoB tells you how many particles there are. Two people with the same LDL cholesterol can have very different particle counts, and it’s the particle count that more directly relates to how much cholesterol gets deposited in artery walls. In people with type 2 diabetes, apoB was significantly associated with coronary artery calcification even after adjusting for other risk factors, while LDL cholesterol was not.18PubMed Central. Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites This discrepancy is especially relevant for people with diabetes, obesity, metabolic syndrome, or high triglycerides, all situations where LDL cholesterol can underestimate the actual atherogenic burden.19PubMed. Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment
Lipoprotein(a), or Lp(a), is another particle worth knowing about. It’s genetically determined, largely unaffected by diet or exercise, and acts as an independent risk factor for cardiovascular disease even when LDL is well controlled.20PubMed Central. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease In the Framingham Heart Study, people with both elevated Lp(a) and LDL above 135 mg/dL had a 43% higher risk of cardiovascular disease compared to those with high LDL alone.21PubMed Central. Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-The Framingham Heart Study Most standard lipid panels don’t include Lp(a), but the American Heart Association recognizes it as a causal risk factor for atherosclerotic disease and recommends that it be measured at least once in a lifetime.22PubMed Central. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease If your total cholesterol is 256 and you have a family history of early heart disease, asking for an Lp(a) test is a reasonable move.
Coronary Artery Calcium Scoring
For someone in a gray zone of risk, where a cholesterol level of 256 raises concern but the standard risk calculators don’t clearly point to medication, coronary artery calcium (CAC) scoring can be a tiebreaker. A CAC scan is a quick, low-dose CT that measures the amount of calcified plaque in your coronary arteries. The result tells you whether atherosclerosis has already started, regardless of what your blood numbers predict.
A score of zero is reassuring. In the Multi-Ethnic Study of Atherosclerosis, people with a CAC score of zero had low event rates regardless of other risk-enhancing factors they carried, with the exception of very low ankle-brachial index.23JAMA Cardiology. Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis A high score, on the other hand, shifts the conversation decisively toward aggressive treatment. Current expert consensus pathways from the American College of Cardiology recommend targeting LDL below 70 mg/dL when the CAC score exceeds 100 or lands above the 75th percentile for your age and sex.24PubMed Central. LDL-C targets based on coronary artery calcium: advancing Figure 6 from the 2022 American college of cardiology expert consensus decision pathway
For someone with a total cholesterol of 256, a CAC score provides concrete information about whether that elevated cholesterol has already begun damaging your arteries. If the score is zero and you’re otherwise healthy, you and your doctor may have more time to try lifestyle modifications. If the score reveals significant calcium deposits, it shifts the urgency considerably.
Genetic Testing and Familial Hypercholesterolemia
If your cholesterol has been stubbornly high since you were young, or if close relatives had heart attacks before age 55 (men) or 65 (women), genetic testing for familial hypercholesterolemia becomes worth considering. FH is caused by mutations in genes that affect how the liver clears LDL, most commonly in the LDL receptor gene, the APOB gene, or the PCSK9 gene. Researchers continue to identify new variants that cause the condition. A recently described variant in the APOB gene, for instance, was found to cause severe hypercholesterolemia and early cardiovascular disease across multiple unrelated families.25PubMed. Novel APOB variant causes familial hypercholesterolemia in multiple unrelated families
Getting a genetic diagnosis matters for two reasons. First, it changes how aggressively your cholesterol should be treated. People with FH are at elevated risk from a young age, and guidelines recommend starting lipid-lowering therapy earlier and targeting lower LDL levels than for the general population. Second, a confirmed FH diagnosis in one family member means that close relatives, including children, should be screened. The condition follows an autosomal dominant pattern, so each first-degree relative has about a 50% chance of carrying the same mutation. Catching it early in a 20-year-old is far more impactful than discovering it after a heart attack at 50.
That said, the absence of a detectable mutation doesn’t mean genetics aren’t involved. As mentioned earlier, most people with very high LDL do not carry a classic FH mutation. Their elevated cholesterol likely reflects the additive effect of many common gene variants, each contributing a small amount, combined with lifestyle factors. The practical takeaway is the same either way: high LDL needs to come down. The genetic test mainly determines how urgently and how aggressively.

